DaVita HealthCare Partners Company Profile (NYSE:DVA)

About DaVita HealthCare Partners

DaVita HealthCare Partners logoDaVita Inc., formerly DaVita HealthCare Partners Inc., is a provider of kidney care services. The Company operates Kidney Care division and HealthCare Partners (HCP) division. The Company's segments include U.S. dialysis and related lab services, HCP and Other-Ancillary services and strategic initiatives. The Company's Kidney Care division is a provider of dialysis services in the United States, treating patients with chronic kidney failure and end stage renal disease (ESRD). HCP division is a patient and physician-focused integrated health care delivery and management company.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Specialized Health Services
  • Sub-Industry: Health Care Services
  • Exchange: NYSE
  • Symbol: DVA
  • CUSIP: 23918K10
Key Metrics:
  • Previous Close: $64.66
  • 50 Day Moving Average: $64.32
  • 200 Day Moving Average: $64.66
  • 52-Week Range: $197,399,000.00 - $54.50
  • Trailing P/E Ratio: 15.59
  • Foreward P/E Ratio: 17.15
  • P/E Growth: 1.38
  • Market Cap: $13.02B
  • Outstanding Shares: 197,399,000
  • Beta: 1.02
Profitability:
  • Net Margins: 4.92%
  • Return on Equity: 16.16%
  • Return on Assets: 4.35%
Debt:
  • Debt-to-Equity Ratio: 1.75%
  • Current Ratio: 1.61%
  • Quick Ratio: 1.54%
Additional Links:
Companies Related to DaVita HealthCare Partners:

Analyst Ratings

Consensus Ratings for DaVita HealthCare Partners (NYSE:DVA) (?)
Ratings Breakdown: 8 Hold Ratings, 3 Buy Ratings
Consensus Rating:Hold (Score: 2.27)
Consensus Price Target: $70.50 (5.38% upside)

Analysts' Ratings History for DaVita HealthCare Partners (NYSE:DVA)
Show:
DateFirmActionRatingPrice TargetDetails
2/17/2017RBC Capital MarketsReiterated RatingHold$62.00View Rating Details
12/13/2016Robert W. BairdDowngradeOutperform -> Neutral$68.00 -> $69.00View Rating Details
11/21/2016Bank of America CorporationReiterated RatingHold$68.00View Rating Details
11/19/2016Jefferies Group LLCReiterated RatingBuy$86.00 -> $70.00View Rating Details
11/1/2016Wells Fargo & CompanyReiterated RatingOutperformView Rating Details
10/13/2016SunTrust Banks, Inc.Set Price TargetHold$66.00View Rating Details
9/20/2016Raymond James Financial, Inc.UpgradeMarket Perform -> Outperform$75.00View Rating Details
9/6/2016Citigroup Inc.Initiated CoverageNeutral$71.00View Rating Details
8/9/2016J P Morgan Chase & CoBoost Price TargetNeutral$74.00 -> $75.00View Rating Details
4/6/2016Susquehanna Bancshares IncBoost Price TargetNeutral$70.00 -> $78.00View Rating Details
3/2/2016Sanford C. BernsteinLower Price TargetMarket Perform$74.50 -> $71.00View Rating Details
2/16/2016Royal Bank Of CanadaLower Price TargetSector Perform$80.00 -> $71.00View Rating Details
2/12/2016William BlairReiterated RatingBuyView Rating Details
2/12/2016Piper Jaffray CompaniesReiterated RatingOverweight$90.00 -> $85.00View Rating Details
2/4/2016Goldman Sachs Group, Inc. (The)Lower Price Target$80.00 -> $76.00View Rating Details
3/13/2015Deutsche Bank AGBoost Price TargetHold$78.00 -> $83.00View Rating Details
(Data available from 2/19/2015 forward)

Earnings

Earnings History for DaVita HealthCare Partners (NYSE:DVA)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/2/2017        
2/16/2017Q4 2016$0.91$0.98$3.74 billion$3.72 billionViewListenView Earnings Details
11/2/2016Q316$0.93$0.95$3.72 billion$3.73 billionViewListenView Earnings Details
8/8/2016Q216$0.98$1.01$3.67 billion$3.72 billionViewListenView Earnings Details
5/4/2016Q116$0.86$0.92$3.51 billion$3.58 billionViewListenView Earnings Details
2/11/2016Q415$0.97$1.01$3.50 billion$3.53 billionViewListenView Earnings Details
11/3/2015Q315$0.97$1.00$3.46 billion$3.53 billionViewListenView Earnings Details
8/4/2015Q215$0.95$0.95$3.37 billion$3.43 billionViewListenView Earnings Details
5/5/2015Q115$0.86$0.86$3.25 billion$3.29 billionViewListenView Earnings Details
2/12/2015Q414$0.89$1.09$3.26 billion$3.33 billionViewListenView Earnings Details
11/6/2014Q314$0.90$0.90$3.19 billion$3.25 billionViewListenView Earnings Details
7/31/2014Q214$0.89$0.95$3.10 billion$3.17 billionViewListenView Earnings Details
5/1/2014Q1$0.86$0.85$3.02 billion$3.04 billionViewListenView Earnings Details
2/11/2014Q413$1.91$0.99$2.92 billion$3.06 billionViewListenView Earnings Details
11/5/2013Q313$0.96$0.98$2.93 billion$3.00 billionViewListenView Earnings Details
8/6/2013Q2 2013$1.84$1.84$2.88 billion$2.87 billionViewListenView Earnings Details
5/7/2013Q1 2013$1.80$1.84$2.78 billion$2.83 billionViewListenView Earnings Details
2/14/2013Q4 2012$1.60$1.85$2.40 billion$2.48 billionViewListenView Earnings Details
10/30/2012$1.55$1.56ViewN/AView Earnings Details
8/1/2012$1.47$1.49ViewN/AView Earnings Details
2/16/2012$1.49$1.58ViewN/AView Earnings Details
11/3/2011$1.46$1.45ViewN/AView Earnings Details
8/3/2011$1.14$1.17ViewN/AView Earnings Details
5/2/2011$0.95$0.96ViewN/AView Earnings Details
2/10/2011$1.12$0.70ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for DaVita HealthCare Partners (NYSE:DVA)
Current Year EPS Consensus Estimate: $3.49 EPS
Next Year EPS Consensus Estimate: $3.90 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20162$0.89$0.95$0.92
Q2 20163$0.98$1.00$0.99
Q3 20163$0.92$0.99$0.96
Q4 20163$0.87$0.95$0.91
Q1 20173$0.77$0.84$0.81
Q2 20173$0.88$0.92$0.90
Q3 20173$0.89$0.93$0.90
Q4 20173$0.82$0.93$0.89
Q1 20181$0.90$0.90$0.90
Q2 20181$1.04$1.04$1.04
Q3 20181$1.04$1.04$1.04
(Data provided by Zacks Investment Research)

Dividends

Dividend History for DaVita HealthCare Partners (NYSE:DVA)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for DaVita HealthCare Partners (NYSE:DVA)
Insider Ownership Percentage: 2.10%
Institutional Ownership Percentage: 85.31%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/9/2016Michael David StaffieriCOOSell20,262$73.09$1,480,949.58View SEC Filing  
7/11/2016Jeanine Marie JigantiInsiderSell1,291$78.51$101,356.41View SEC Filing  
7/1/2016Jeanine Marie JigantiInsiderSell4,620$77.45$357,819.00View SEC Filing  
5/25/2016Pamela M ArwayDirectorSell10,824$77.16$835,179.84View SEC Filing  
5/23/2016James K HilgerCFOSell3,416$76.79$262,314.64View SEC Filing  
5/20/2016Kent J ThiryCEOSell32,880$76.99$2,531,431.20View SEC Filing  
5/17/2016Dennis KogodCEOSell17,700$77.35$1,369,095.00View SEC Filing  
5/17/2016Leanne M ZumwaltVPSell538$77.08$41,469.04View SEC Filing  
5/16/2016James K HilgerCFOSell3,983$75.59$301,074.97View SEC Filing  
5/16/2016Javier RodriguezCEOSell36,466$75.44$2,750,995.04View SEC Filing  
5/16/2016Michael David StaffieriCOOSell4,934$75.69$373,454.46View SEC Filing  
5/12/2016Roger ValineDirectorSell8,220$76.34$627,514.80View SEC Filing  
5/10/2016Dennis KogodCEOSell40,048$76.25$3,053,660.00View SEC Filing  
5/6/2016John M NehraDirectorSell16,314$75.56$1,232,685.84View SEC Filing  
4/11/2016Javier RodriguezCEOSell89,912$73.51$6,609,431.12View SEC Filing  
3/21/2016Dennis KogodCEOSell13,455$72.12$970,374.60View SEC Filing  
2/29/2016Pamela M ArwayDirectorSell9,026$66.00$595,716.00View SEC Filing  
2/23/2016Leanne M. ZumwaltVPSell14,587$64.25$937,214.75View SEC Filing  
2/16/2016Dennis KogodCEOSell33,290$61.99$2,063,647.10View SEC Filing  
12/17/2015Laura MildenbergerinsiderSell1,440$68.14$98,121.60View SEC Filing  
9/22/2015Kim M. RiverainsiderSell40,037$75.48$3,021,992.76View SEC Filing  
8/17/2015Carol Anthony DavidsonDirectorSell4,038$79.93$322,757.34View SEC Filing  
6/4/2015Robert J MargolisChairmanSell31,400$83.39$2,618,446.00View SEC Filing  
5/28/2015Michael David StaffieriCOOSell9,050$84.07$760,833.50View SEC Filing  
5/19/2015Robert J MargolisChairmanSell15,700$83.22$1,306,554.00View SEC Filing  
5/18/2015James K HilgerCFOSell3,983$82.10$327,004.30View SEC Filing  
5/18/2015Michael David StaffieriCOOSell2,047$82.03$167,915.41View SEC Filing  
5/18/2015Robert J MargolisChairmanSell15,700$82.24$1,291,168.00View SEC Filing  
5/11/2015James K HilgerCFOSell8,267$82.00$677,894.00View SEC Filing  
5/11/2015Jeanine Marie JigantiInsiderSell2,481$81.95$203,317.95View SEC Filing  
5/11/2015John M NehraDirectorSell12,278$81.85$1,004,954.30View SEC Filing  
4/21/2015Robert J MargolisChairmanSell31,400$82.40$2,587,360.00View SEC Filing  
4/7/2015Robert J MargolisChairmanSell15,700$82.15$1,289,755.00View SEC Filing  
4/6/2015Robert J MargolisChairmanSell15,700$81.49$1,279,393.00View SEC Filing  
3/27/2015Robert J MargolisChairmanSell31,400$81.18$2,549,052.00View SEC Filing  
3/12/2015Robert J MargolisChairmanSell107,374$79.24$8,508,315.76View SEC Filing  
2/27/2015Robert J MargolisChairmanSell21,000$74.29$1,560,090.00View SEC Filing  
2/19/2015Robert J MargolisChairmanSell21,000$73.12$1,535,520.00View SEC Filing  
1/30/2015Robert J MargolisChairmanSell31,400$75.48$2,370,072.00View SEC Filing  
1/23/2015Michael David StaffieriCOOSell21,869$76.05$1,663,137.45View SEC Filing  
1/16/2015Robert J MargolisChairmanSell31,400$74.92$2,352,488.00View SEC Filing  
1/8/2015Kim M RiveraInsiderSell1,111$75.10$83,436.10View SEC Filing  
12/30/2014Robert J MargolisChairmanSell31,400$76.09$2,389,226.00View SEC Filing  
12/29/2014Robert J MargolisChairmanSell15,700$76.09$1,194,613.00View SEC Filing  
12/19/2014Laura MildenbergerInsiderSell1,446$75.50$109,173.00View SEC Filing  
12/18/2014Robert J MargolisChairmanSell31,400$74.67$2,344,638.00View SEC Filing  
12/3/2014Robert J MargolisChairmanSell31,400$75.80$2,380,120.00View SEC Filing  
12/1/2014Kim M RiveraInsiderSell6,503$76.08$494,748.24View SEC Filing  
11/21/2014Robert J MargolisChairmanSell31,400$75.08$2,357,512.00View SEC Filing  
11/11/2014Kent J ThiryCEOSell344,938$74.52$25,704,779.76View SEC Filing  
11/11/2014Robert J MargolisChairmanSell250,000$75.09$18,772,500.00View SEC Filing  
11/10/2014Berkshire Hathaway IncMajor ShareholderBuy944,418$74.11$69,990,817.98View SEC Filing  
11/7/2014R. Ted WeschlerMajor ShareholderBuy820,018$74.10$60,763,333.80View SEC Filing  
11/3/2014Roger ValineDirectorSell7,185$77.85$559,352.25View SEC Filing  
9/16/2014John M NehraDirectorSell20,000$73.91$1,478,200.00View SEC Filing  
9/8/2014Kim M RiveraInsiderSell1,111$74.25$82,491.75View SEC Filing  
8/27/2014Leanne M ZumwaltVPSell3,214$74.57$239,667.98View SEC Filing  
8/11/2014Jeanine Marie JigantiInsiderSell2,500$72.14$180,350.00View SEC Filing  
6/11/2014Kim M RiveraInsiderSell5,929$71.05$421,255.45View SEC Filing  
5/29/2014Laura MildenbergerInsiderSell5,080$69.99$355,549.20View SEC Filing  
5/16/2014Dennis KogodCOOSell18,750$67.30$1,261,875.00View SEC Filing  
5/16/2014Kent ThiryCEOSell17,600$67.41$1,186,416.00View SEC Filing  
5/15/2014James HilgerCAOSell1,666$67.23$112,005.18View SEC Filing  
5/15/2014Javier RodriguezCEOSell7,000$67.50$472,500.00View SEC Filing  
5/12/2014Dennis KogodCOOSell32,188$68.06$2,190,715.28View SEC Filing  
5/8/2014Dennis KogodCOOSell32,213$67.36$2,169,867.68View SEC Filing  
5/7/2014Michael David StaffieriCOOSell2,633$67.30$177,200.90View SEC Filing  
4/2/2014Michael David StaffieriCOOSell2,867$69.15$198,253.05View SEC Filing  
3/20/2014Laura MildenbergerInsiderSell3,274$70.04$229,310.96View SEC Filing  
2/26/2014R. Ted Weschlermajor shareholderBuy1,159,858$66.97$77,675,690.26View SEC Filing  
2/21/2014John NehraDirectorSell40,000$65.81$2,632,400.00View SEC Filing  
2/18/2014William RoperDirectorSell42,519$66.37$2,821,986.03View SEC Filing  
12/20/2013Laura MildenbergerInsiderSell10,417$62.53$651,375.01View SEC Filing  
12/17/2013Allen NissensonInsiderSell2,929$59.83$175,242.07View SEC Filing  
12/9/2013Berkshire Hathaway Incmajor shareholderBuy1,314,170$57.84$76,011,592.80View SEC Filing  
11/8/2013R. Ted Weschlermajor shareholderBuy3,700,294$55.14$204,034,211.16View SEC Filing  
7/5/2013Berkshire Hathaway IncMajor ShareholderBuy110,309$114.01$12,576,329.09View SEC Filing  
7/3/2013R. Ted WeschlerMajor ShareholderBuy639,200$114.78$73,367,376.00View SEC Filing  
5/15/2013David T ShapiroInsiderSell8,779$129.80$1,139,514.20View SEC Filing  
5/15/2013Dennis KogodCOOSell21,130$129.47$2,735,701.10View SEC Filing  
5/15/2013James K HilgerCFOSell1,049$130.18$136,558.82View SEC Filing  
5/15/2013Leanne M ZumwaltVPSell13,209$129.59$1,711,754.31View SEC Filing  
5/13/2013Kent J ThiryCEOSell243,307$129.95$31,617,744.65View SEC Filing  
5/13/2013Kim M RiveraInsiderSell1,672$129.70$216,858.40View SEC Filing  
3/4/2013Berkshire Hathaway IncMajor ShareholderBuy164,947$119.59$19,726,011.73View SEC Filing  
3/4/2013Roger ValineDirectorSell1,390$120.00$166,800.00View SEC Filing  
2/27/2013Berkshire Hathaway IncMajor ShareholderBuy211,889$116.56$24,697,781.84View SEC Filing  
2/22/2013Berkshire Hathaway IncMajor ShareholderBuy224,091$115.88$25,967,665.08View SEC Filing  
2/19/2013Berkshire Hathaway IncMajor ShareholderBuy323,070$116.73$37,711,961.10View SEC Filing  
2/5/2013Berkshire Hathaway IncMajor ShareholderBuy32,376$115.17$3,728,743.92View SEC Filing  
2/4/2013Roger ValineDirectorSell1,389$116.13$161,304.57View SEC Filing  
1/16/2013Berkshire Hathaway IncMajor ShareholderBuy42,400$111.33$4,720,392.00View SEC Filing  
1/15/2013Berkshire Hathaway IncMajor ShareholderBuy179,300$109.67$19,663,831.00View SEC Filing  
1/10/2013Berkshire Hathaway IncMajor ShareholderBuy187,898$109.54$20,582,346.92View SEC Filing  
12/24/2012Dennis KogodCOOSell12,736$111.00$1,413,696.00View SEC Filing  
12/21/2012James K HilgerCFOSell2,073$112.20$232,590.60View SEC Filing  
12/6/2012Berkshire Hathaway IncMajor ShareholderBuy635,633$106.20$67,504,224.60View SEC Filing  
11/29/2012Berkshire Hathaway IncMajor ShareholderBuy679,249$108.20$73,494,741.80View SEC Filing  
11/26/2012Berkshire Hathaway IncMajor ShareholderBuy412,050$110.38$45,482,079.00View SEC Filing  
11/16/2012Berkshire Hathaway IncMajor ShareholderBuy132,958$112.45$14,951,127.10View SEC Filing  
11/12/2012Berkshire Hathaway IncMajor ShareholderBuy548,823$112.15$61,550,499.45View SEC Filing  
11/7/2012Berkshire Hathaway IncMajor ShareholderBuy139,491$112.03$15,627,176.73View SEC Filing  
11/2/2012Berkshire Hathaway IncMajor ShareholderBuy254,750$112.20$28,582,950.00View SEC Filing  
10/26/2012Berkshire Hathaway IncMajor ShareholderBuy257,941$111.14$28,667,562.74View SEC Filing  
10/17/2012Berkshire Hathaway IncMajor ShareholderBuy63,928$109.56$7,003,951.68View SEC Filing  
10/12/2012Berkshire Hathaway IncMajor ShareholderBuy217,597$109.76$23,883,446.72View SEC Filing  
10/9/2012Berkshire Hathaway IncMajor ShareholderBuy67,946$107.71$7,318,463.66View SEC Filing  
9/28/2012Berkshire Hathaway IncMajor ShareholderBuy282,403$102.03$28,813,578.09View SEC Filing  
8/8/2012Kent J ThiryChairmanSell320,877$96.88$31,086,563.76View SEC Filing  
8/7/2012William L RoperDirectorSell23,019$95.95$2,208,673.05View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for DaVita HealthCare Partners (NYSE:DVA)
DateHeadline
investornewswire.com logoDaVita healthCare Partners Inc. (NYSE:DVA) Strong Sell Recommendations At 0 - Investor Newswire (NYSE:DVA)
www.investornewswire.com - February 18 at 4:34 PM
seekingalpha.com logoDaVita HealthCare Partners beats by $0.07, misses on revenue (NYSE:DVA)
seekingalpha.com - February 18 at 9:53 AM
cnbc.com logoDaVita HealthCare beats 4Q profit forecasts (NYSE:DVA)
www.cnbc.com - February 18 at 9:53 AM
us.rd.yahoo.com logoDialysis service provider DaVita's profit beats estimates (NYSE:DVA)
us.rd.yahoo.com - February 18 at 9:53 AM
bizjournals.com logoAfter successful 2016, DaVita predicts income drop in 2017 (NYSE:DVA)
us.rd.yahoo.com - February 18 at 9:53 AM
thestreet.com logoDaVita Shares Rise on Positive Earnings (NYSE:DVA)
us.rd.yahoo.com - February 18 at 9:53 AM
us.rd.yahoo.com logoEdited Transcript of DVA earnings conference call or presentation 16-Feb-17 10:00pm GMT (NYSE:DVA)
us.rd.yahoo.com - February 18 at 9:53 AM
feeds.benzinga.com logoSHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of DaVita Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of April 3, 2017 – DVA (NYSE:DVA)
feeds.benzinga.com - February 17 at 11:12 AM
nasdaq.com logoDaVita HealthCare Partners Inc. Reveals 10% Decline In Q4 Profit - Nasdaq (NYSE:DVA)
www.nasdaq.com - February 17 at 10:05 AM
News IconTrading Chatter: Chart Watch For DaVita HealthCare Partners Inc. (DVA) - Midway Monitor (NYSE:DVA)
midwaymonitor.com - February 16 at 3:25 PM
finance.yahoo.com logoKessler Topaz Meltzer & Check, LLP Announces Shareholder Lawsuit Filed against DaVita Inc. (NYSE:DVA)
finance.yahoo.com - February 16 at 3:25 PM
finance.yahoo.com logoDVA LOSS NOTICE: Rosen Law Firm Reminds DaVita Inc. Investors of Important Deadline in Class Action (NYSE:DVA)
finance.yahoo.com - February 16 at 3:25 PM
finance.yahoo.com logoClaims and starts — What you need to know in markets on Thursday (NYSE:DVA)
finance.yahoo.com - February 16 at 3:25 PM
biz.yahoo.com logoQ4 2016 DaVita Inc Earnings Release - After Market Close (NYSE:DVA)
biz.yahoo.com - February 16 at 3:25 PM
realistinvestor.com logoDaVita healthCare Partners Inc. (NYSE:DVA) Mean Rating At $2.22 - RealistInvestor.com (NYSE:DVA)
www.realistinvestor.com - February 14 at 10:44 PM
us.rd.yahoo.com logoINVESTOR ALERT: Brower Piven Encourages Shareholders Who Have Losses In Excess Of $100,000 From Investment In DaVita Inc. To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit (NYSE:DVA)
us.rd.yahoo.com - February 14 at 5:44 PM
4-traders.com logoDavita Inc : Lundin Law PC Announces Securities Class Action Lawsuit against DaVita Inc. and Encourages Investors with Losses to Contact the Firm (NYSE:DVA)
www.4-traders.com - February 13 at 10:36 PM
finance.yahoo.com logoINVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders of DaVita Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of April 3, 2017 - DVA (NYSE:DVA)
finance.yahoo.com - February 13 at 5:34 PM
feeds.benzinga.com logoLawsuit for Investors in Davita Inc (NYSE:DVA) shares announced by Shareholders Foundation (NYSE:DVA)
feeds.benzinga.com - February 13 at 1:25 PM
finance.yahoo.com logoSHAREHOLDER ALERT: Class Action Lawsuit Filed Against DaVita Inc. - DVA (NYSE:DVA)
finance.yahoo.com - February 11 at 9:57 PM
us.rd.yahoo.com logoSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in DaVita Inc. of Class Action Lawsuit and Upcoming Deadline - DVA (NYSE:DVA)
us.rd.yahoo.com - February 10 at 10:20 PM
finance.yahoo.com logoCan Allscripts (MDRX) Surprise Investors in Q4 Earnings? (NYSE:DVA)
finance.yahoo.com - February 10 at 5:18 PM
us.rd.yahoo.com logoGovernment Report Shows DaVita Has Top Clinical Outcomes (NYSE:DVA)
us.rd.yahoo.com - February 8 at 5:20 PM
finance.yahoo.com logoDENTSPLY (XRAY) Q4 Earnings: Is Disappointment in Store? (NYSE:DVA)
finance.yahoo.com - February 8 at 5:20 PM
finance.yahoo.com logoIMPORTANT SHAREHOLDER ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against DaVita Inc. and Encourages Investors with Losses to Contact the Firm (NYSE:DVA)
finance.yahoo.com - February 7 at 11:01 PM
us.rd.yahoo.com logoWhy Earnings Season Could Be Great for DaVita (DVA) (NYSE:DVA)
us.rd.yahoo.com - February 7 at 5:59 PM
us.rd.yahoo.com logoWill Q4 Earnings Hold a Surprise for DaVita (DVA) Stock? (NYSE:DVA)
us.rd.yahoo.com - February 7 at 5:59 PM
us.rd.yahoo.com logoGlancy Prongay & Murray Announces the Filing of a Securities Class Action on Behalf of DaVita Inc. Investors and Encourages Investors to Contact the Firm (NYSE:DVA)
us.rd.yahoo.com - February 7 at 5:59 PM
us.rd.yahoo.com logoShareholder Class Action Lawsuit Filed Against DaVita Inc. - DVA (NYSE:DVA)
us.rd.yahoo.com - February 7 at 5:59 PM
finance.yahoo.com logoIMPORTANT EQUITY ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against DaVita Inc. and Encourages Investors with Losses to Contact the Firm (NYSE:DVA)
finance.yahoo.com - February 7 at 5:59 PM
finance.yahoo.com logoPawar Law Group Announces the Filing of a Securities Class Action Lawsuit Against DaVita Inc. – DVA (NYSE:DVA)
finance.yahoo.com - February 7 at 5:59 PM
feeds.benzinga.com logoSHAREHOLDER ALERT: Brower Piven Notifies Investors of Class Action Lawsuit And Encourages Those Who Have Losses In Excess Of $100,000 From Investment In DaVita Inc. (DVA) To Contact Brower Piven Before The Lead Plaintiff Deadline (NYSE:DVA)
feeds.benzinga.com - February 7 at 2:55 PM
nasdaq.com logoCan Humana (HUM) Pull a Surprise This Earnings Season? (NYSE:DVA)
www.nasdaq.com - February 6 at 4:53 PM
News IconHartford Investment Management Co Increased Davita INC (DVA) Holding by $3.36 Million as Stock Price Declined (NYSE:DVA)
randolphguide.com - February 6 at 4:53 PM
finance.yahoo.com logoIMPORTANT EQUITY ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against DaVita Inc. and Encourages Investors with Losses to Contact the Firm (NYSE:DVA)
finance.yahoo.com - February 6 at 4:53 PM
finance.yahoo.com logo4 Healthcare Players Likey to Trump Q4 Earnings Estimates (NYSE:DVA)
finance.yahoo.com - February 6 at 4:53 PM
finance.yahoo.com logoSafirstein Metcalf LLP Announces That A Class Action Lawsuit Has Been Filed Against DaVita, Inc. - DVA (NYSE:DVA)
finance.yahoo.com - February 6 at 4:53 PM
feeds.benzinga.com logoDVA SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notifies Investors of a Class Action Involving DaVita Inc. and a Lead Plaintiff Deadline of April 3, 2017 (NYSE:DVA)
feeds.benzinga.com - February 6 at 12:24 PM
finance.yahoo.com logoDaVita Inc. Schedules 4th Quarter 2016 Investor Conference Call (NYSE:DVA)
finance.yahoo.com - February 6 at 8:39 AM
finance.yahoo.com logoRobbins Arroyo LLP: DaVita Inc. (DVA) Misled Shareholders According to a Recently Filed Class Action (NYSE:DVA)
finance.yahoo.com - February 3 at 10:14 PM
finance.yahoo.com logoIMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against DaVita Inc. and Encourages Investors with Losses to Contact the Firm (NYSE:DVA)
finance.yahoo.com - February 3 at 10:14 PM
finance.yahoo.com logoThe Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of DaVita Inc. Investors and Encourages Investors to Contact the Firm (NYSE:DVA)
finance.yahoo.com - February 3 at 5:12 PM
finance.yahoo.com logoSHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against DaVita Inc. and Certain Officers – DVA (NYSE:DVA)
finance.yahoo.com - February 3 at 5:12 PM
feeds.benzinga.com logoSHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against DaVita Inc. and Certain Officers – DVA (NYSE:DVA)
feeds.benzinga.com - February 3 at 2:48 PM
finance.yahoo.com logoIMPORTANT INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against DaVita Inc. and Encourages Investors with Losses to Contact the Firm (NYSE:DVA)
finance.yahoo.com - February 3 at 3:20 AM
finance.yahoo.com logoINVESTOR ALERT: Goldberg Law PC Announces the Filing of a Securities Class Action Lawsuit against DaVita Inc. and Encourages Investors with Losses to Contact the Firm (NYSE:DVA)
finance.yahoo.com - February 2 at 5:18 PM
finance.yahoo.com logoEQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against DaVita Inc. – DVA (NYSE:DVA)
finance.yahoo.com - February 2 at 5:18 PM
finance.yahoo.com logoIMPORTANT INVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against DaVita Inc. and Encourages Investors with Losses to Contact the Firm (NYSE:DVA)
finance.yahoo.com - February 2 at 5:18 PM
finance.yahoo.com logoSHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against DaVita Inc. (DVA) & Lead Plaintiff Deadline - April 3, 2017 (NYSE:DVA)
finance.yahoo.com - February 2 at 5:17 PM
moodys.com logoDaVita Inc. -- Moody's: DaVita settlement is credit positive (NYSE:DVA)
www.moodys.com - February 2 at 5:17 PM

Social

What is DaVita HealthCare Partners' stock symbol?

DaVita HealthCare Partners trades on the New York Stock Exchange (NYSE) under the ticker symbol "DVA."

Where is DaVita HealthCare Partners' stock going? Where will DaVita HealthCare Partners' stock price be in 2017?

11 brokers have issued twelve-month price objectives for DaVita HealthCare Partners' shares. Their forecasts range from $62.00 to $78.00. On average, they anticipate DaVita HealthCare Partners' stock price to reach $70.50 in the next year.

When will DaVita HealthCare Partners announce their earnings?

DaVita HealthCare Partners is scheduled to release their next quarterly earnings announcement on Tuesday, May, 2nd 2017.

Who owns DaVita HealthCare Partners stock?

DaVita HealthCare Partners' stock is owned by a number of of retail and institutional investors. Top institutional shareholders include Russell Investments Group Ltd. (0.07%), Flinton Capital Management LLC (0.04%), Tyers Asset Management LLC (0.04%), Pitcairn Co. (0.01%), Cigna Investments Inc. New (0.00%) and Roundview Capital LLC (0.00%). Company insiders that own DaVita HealthCare Partners stock include Carol Anthony Davidson, Dennis Kogod, James K Hilger, Javier Rodriguez, Jeanine Marie Jiganti, John M Nehra, Kent J Thiry, Kim M Rivera, Laura Mildenberger, Leanne M Zumwalt, Michael David Staffieri, Pamela M Arway, Robert J Margolis and Roger Valine.

Who sold DaVita HealthCare Partners stock? Who is selling DaVita HealthCare Partners stock?

DaVita HealthCare Partners' stock was sold by a variety of institutional investors in the last quarter, including Pitcairn Co. and Roundview Capital LLC. Company insiders that have sold DaVita HealthCare Partners stock in the last year include Dennis Kogod, James K Hilger, Javier Rodriguez, Jeanine Marie Jiganti, John M Nehra, Kent J Thiry, Leanne M Zumwalt, Michael David Staffieri, Pamela M Arway and Roger Valine.

Who bought DaVita HealthCare Partners stock? Who is buying DaVita HealthCare Partners stock?

DaVita HealthCare Partners' stock was bought by a variety of institutional investors in the last quarter, including Russell Investments Group Ltd., Flinton Capital Management LLC, Tyers Asset Management LLC, Cigna Investments Inc. New, Smith Shellnut Wilson LLC ADV and SRS Capital Advisors Inc..

How do I buy DaVita HealthCare Partners stock?

Shares of DaVita HealthCare Partners can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of DaVita HealthCare Partners stock cost?

One share of DaVita HealthCare Partners stock can currently be purchased for approximately $66.90.

DaVita HealthCare Partners (NYSE:DVA) Chart for Sunday, February, 19, 2017


Institutional Ownership Chart

Institutional Ownership by Quarter for DaVita HealthCare Partners (NYSE:DVA)

Earnings History Chart

Earnings by Quarter for DaVita HealthCare Partners (NYSE:DVA)

Dividend History Chart

Dividend Payments by Quarter for DaVita HealthCare Partners (NYSE:DVA)

Last Updated on 2/19/2017 by MarketBeat.com Staff